Companies seeking to navigate uncertainties arising from the U.S-China trade relationship can take a proactive posture to enhance the competitiveness of domestic production.
American manufacturers rushing to bring production back home from Asia? Time for a reality check, according to the latest Reshoring Index from Kearney.
As part of the probe, the DOC is calling on companies to comment on their projected demand for affected products, and the potential for foreign control or exploitation of related supply chains.
In Pharma and Life Sciences, compliance underpins every link in the global supply chain. Organizations must manage complex partner networks, navigate evolving regulations, and mitigate risk across operations—all while adopting emerging technologies like AI safely and efficiently.
The announcement came at the start of U.S. President Donald Trump's visit to the U.K., as drugmakers face pressure from the Trump administration to move production to the U.S.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.